K-numberK250805
Device nameDeVilbiss PulmO2 10-Liter Oxygen Concentrator (1060AW)
ApplicantDevilbiss Healthcare, LLC
Product codeCAW
Device classClass II
Decision dateDec 9, 2025
DecisionSubstantially Equivalent
Regulation868.5440
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DeVilbiss PulmO2 10-Liter Oxygen Concentrator is a portable medical device that extracts nitrogen from room air using pressure swing adsorption to produce oxygen-enriched gas. It delivers supplemental oxygen at adjustable flow rates (1–10 liters per minute) to adult and pediatric patients weighing over 10 kg in home or institutional settings, and is not intended to be life-sustaining.

Technological characteristics

The device uses pressure swing adsorption with molecular sieve technology, operates on universal AC power (100–240 VAC, 50/60 Hz), delivers oxygen at 87%–96% concentration with regulated outlet pressure of 8.5 PSIG, and includes multiple safety alarms. Key differences from the predicate (JUMAO 5L/min device) include doubled flow capacity (10 vs. 5 LPM), universal power supply versus fixed voltage, and expanded alarm diagnostics, though both share identical product code (CAW) and operating principles.

Test standards cited

Testing conducted per ISO 18562 series (breathing gas pathway biocompatibility), ISO 10993-17 (toxicological risk assessment), ISO 80601-2-69 (oxygen concentrator safety and performance), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-1-8 (alarm systems), IEC 60601-1-11 (home healthcare use), IEC 62304 (software life cycle), ANSI/AAMI/IEC 62366-1 (usability engineering), and ISTA 3A (packaging/shipment).

Substantial equivalence argument

Substantial equivalence is established through identical product code (CAW), equivalent intended use (supplemental oxygen provision), same pressure swing adsorption technology with molecular sieves, biocompatible materials, and comprehensive performance testing demonstrating safety and effectiveness equivalent to the predicate. Technological differences (higher flow capacity, universal power, expanded alarms) do not raise new safety or effectiveness questions and are attributable to enhanced capability rather than fundamental design changes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →